Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

Description

This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

Conditions

Asthma in Children, Asthma Attack

Study Overview

Study Details

Study overview

This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation

Condition
Asthma in Children
Intervention / Treatment

-

Contacts and Locations

Oklahoma City

Oklahoma Children's Hospital, Oklahoma City, Oklahoma, United States, 73104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ages 5-17 years old
  • * Presents to the ED with a respiratory score in the "Moderate" range (6
  • * Parent(s)/Caregiver(s) speak English
  • * Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congenital heart disease, tracheostomy dependent, myasthenia gravis patients
  • * Patients who are pregnant
  • * Parent(s)/Caregiver(s) do not speak English

Ages Eligible for Study

5 Years to 17 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Oklahoma,

Ryan McKee, MD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

2025-05-31